These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

280 related items for PubMed ID: 22010875

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Evaluation of the diagnostic value of serum tumor markers, and fecal k-ras and p53 gene mutations for pancreatic cancer.
    Wu X, Lu XH, Xu T, Qian JM, Zhao P, Guo XZ, Yang XO, Jiang WJ.
    Chin J Dig Dis; 2006; 7(3):170-4. PubMed ID: 16808798
    [Abstract] [Full Text] [Related]

  • 23. Autoantibodies against tumor-associated antigens in the early detection of lung cancer.
    Dai L, Tsay JC, Li J, Yie TA, Munger JS, Pass H, Rom WN, Zhang Y, Tan EM, Zhang JY.
    Lung Cancer; 2016 Sep; 99():172-9. PubMed ID: 27565936
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Autoantibodies to tumor-associated antigens combined with abnormal alpha-fetoprotein enhance immunodiagnosis of hepatocellular carcinoma.
    Chen Y, Zhou Y, Qiu S, Wang K, Liu S, Peng XX, Li J, Tan EM, Zhang JY.
    Cancer Lett; 2010 Mar 01; 289(1):32-9. PubMed ID: 19683863
    [Abstract] [Full Text] [Related]

  • 27. Analyses of autoantibodies against tumor-associated antigens in patients with hepatocellular carcinoma.
    Himoto T, Kuriyama S, Zhang JY, Chan EK, Kimura Y, Masaki T, Uchida N, Nishioka M, Tan EM.
    Int J Oncol; 2005 Oct 01; 27(4):1079-85. PubMed ID: 16142326
    [Abstract] [Full Text] [Related]

  • 28. Tumor-associated antigen arrays to enhance antibody detection for cancer diagnosis.
    Zhang JY.
    Cancer Detect Prev; 2004 Oct 01; 28(2):114-8. PubMed ID: 15068835
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Using immunomic approach to enhance tumor-associated autoantibody detection in diagnosis of hepatocellular carcinoma.
    Dai L, Ren P, Liu M, Imai H, Tan EM, Zhang JY.
    Clin Immunol; 2014 Oct 01; 152(1-2):127-39. PubMed ID: 24667685
    [Abstract] [Full Text] [Related]

  • 31. The COOH-terminal Src kinase Csk is a tumor antigen in human carcinoma.
    Bénistant C, Bourgaux JF, Chapuis H, Mottet N, Roche S, Bali JP.
    Cancer Res; 2001 Feb 15; 61(4):1415-20. PubMed ID: 11245444
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. The detection of serum anti-p53 antibodies from patients with gastric carcinoma in China.
    Qiu LL, Hua PY, Ye LL, Wang YC, Qiu T, Bao HZ, Wang L.
    Cancer Detect Prev; 2007 Feb 15; 31(1):45-9. PubMed ID: 17292563
    [Abstract] [Full Text] [Related]

  • 35. Using recursive partitioning approach to select tumor-associated antigens in immunodiagnosis of gastric adenocarcinoma.
    Qin J, Wang S, Shi J, Ma Y, Wang K, Ye H, Zhang X, Wang P, Wang X, Song C, Dai L, Wang K, Jiang B, Zhang J.
    Cancer Sci; 2019 Jun 15; 110(6):1829-1841. PubMed ID: 30950146
    [Abstract] [Full Text] [Related]

  • 36. Human Blood Autoantibodies in the Detection of Colorectal Cancer.
    Negm OH, Hamed MR, Schoen RE, Whelan RL, Steele RJ, Scholefield J, Dilnot EM, Shantha Kumara HM, Robertson JF, Sewell HF.
    PLoS One; 2016 Jun 15; 11(7):e0156971. PubMed ID: 27383396
    [Abstract] [Full Text] [Related]

  • 37. The clinical value of serum CEA, CA19-9, and CA242 in the diagnosis and prognosis of pancreatic cancer.
    Ni XG, Bai XF, Mao YL, Shao YF, Wu JX, Shan Y, Wang CF, Wang J, Tian YT, Liu Q, Xu DK, Zhao P.
    Eur J Surg Oncol; 2005 Mar 15; 31(2):164-9. PubMed ID: 15698733
    [Abstract] [Full Text] [Related]

  • 38. Usefulness of serum anti-p53 antibody assay for lung cancer diagnosis.
    Park Y, Kim Y, Lee JH, Lee EY, Kim HS.
    Arch Pathol Lab Med; 2011 Dec 15; 135(12):1570-5. PubMed ID: 22129186
    [Abstract] [Full Text] [Related]

  • 39. Preferential humoral immune response in prostate cancer to cellular proteins p90 and p62 in a panel of tumor-associated antigens.
    Shi FD, Zhang JY, Liu D, Rearden A, Elliot M, Nachtsheim D, Daniels T, Casiano CA, Heeb MJ, Chan EK, Tan EM.
    Prostate; 2005 May 15; 63(3):252-8. PubMed ID: 15538718
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.